Tech Company Financing Transactions
Alveolus Bio Funding Round
Alveolus Bio closed a financing round on 8/4/2025. Investors included Shilpa Medicare.
Transaction Overview
Company Name
Announced On
8/4/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 1st Ave N
Birmingham, AL 35203
USA
Birmingham, AL 35203
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Pioneering biotherapeutic delivery for the prevention and treatment of chronic lung disease. We are a team of scientists, clinicians, and engineers on a mission to disrupt the standard of care for chronic and infectious lung disease. Our proprietary resMIT platform delivers safe, targeted bacteria directly to the lungs to address fibroblast dysfunction in Idiopathic Pulmonary Fibrosis (IPF) and neutrophilic inflammation indications (NCFBE, COPD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gaurav Mehta
Founder
Vivek Lal
VP - R & D
Teodora Nicola
Browse more venture capital transactions:
Prev: 8/4/2025: Comp AI venture capital transaction
Next: 8/4/2025: Blue J venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs